superficial & orthovoltage x-ray equipment

New Xstrahl (Gulmay) Superficial & Orthovoltage X-ray Therapy Systems

Xstrahl is the leading designer and manufacturer of X-ray therapy systems for use in cancer and dermatology treatment as well as radiation biology research, providing complete and specialized clinical solutions to advance radiation oncology.

Xstrahl’s superficial and orthovoltage radiotherapy systems are the choice of leading clinical centers across the world to deliver effective treatments for skin cancer and other dermatological disorders, as well as providing palliation for secondary lesions.

TRG works closely with Xstrahl  to provide an unsurpassed level of service from initial specification and suite design through installation and ongoing training, education and maintenance. With a unique, in-depth understanding of the clinical environment and radiography techniques, the TRG / Xstrahl team ensures an unrivalled level of clinical training to users of its products.

Xstrahl 100 and 150

xtrahl 150The Xstrahl 100 and 150 X-ray therapy systems offer a low energy option for superficial treatment of clinical indications including: basal cell carcinoma, squamous cell carcinoma, keloid scars, dermatological conditions and mycosis fungoides. The higher energy range of the 150 X-ray systems enables deeper skin lesions to be treated.



Xstrahl 200 and 300

The Xstrahl 200 and 300 X-ray therapy systems are also suitable for treating all the superficial conditions outlined above. The additional orthovoltage capability makes them ideal for providing palliative treatment and treatment of benign conditions including: inflammatory disorders, degenerative disorders and hypertrophic disorders.


Headquartered in the UK, Xstrahl has manufacturing facilities both in the UK and US and operates globally through its international network of distributors. TRG offers the full range of Xstrahl x-ray therapy equipment to facilities throughout the U.S.